Table 3.
Multivariate analysis for PFS of R/M HNSCC patients.
| Factors | Sig. | Exp(B) | 95.0%Cl for Exp(B) | |
|---|---|---|---|---|
| Lower | Upper | |||
| Sex (Male vs Female) |
.616 | .836 | .416 | 1.681 |
| Age (≥60vs<60) |
.684 | 1.152 | .584 | 2.273 |
| Primary tumor site (Oral vs Oropharyngeal) |
.615 | 1.411 | .369 | 5.392 |
| Recurrence pattern | .142 | .616 | .323 | 1.175 |
| HPV infection (Positive vs Negative) |
.743 | 1.488 | .138 | 15.991 |
| ECOG PS (1 vs 2) |
.061 | 2.386 | .960 | 5.935 |
| First-line therapy vs ≥2nd line therapy | .001 | .265 | .118 | .592 |
| irAEs vs No irAEs | .016 | .297 | .110 | .800 |